Seelos Therapeutics Investor Relations Material
Latest events
Q2 2024
14 Aug, 2024
Q1 2024
14 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Seelos Therapeutics Inc
Access all reports
Seelos Therapeutics, Inc. is a biotechnology company focused on developing treatments for central nervous system disorders and other rare diseases. The company’s research and development efforts target neurological, psychiatric, and neurodegenerative conditions. The company is headquartered in New York, New York, and its shares are listed on the OTCQB.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
SEEL.Q
Country
🇺🇸 United States